XASXHPC
Market cap3mUSD
Dec 20, Last price
0.02AUD
Name
Hydration Pharmaceuticals Co Ltd
Chart & Performance
P/E
—
P/S
0.32
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
28.01%
Rev. gr., 5y
19.27%
Revenues
10m
+10.34%
Net income
-8m
L-23.61%
CFO
-6m
L-41.24%
Earnings
May 23, 2025
Profile
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The company was founded in 2001 and is headquartered in San Diego, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 10,041 10.34% | 9,100 53.75% | 5,919 57.55% | |||
Cost of revenue | 17,783 | 19,802 | 12,653 | |||
Unusual Expense (Income) | ||||||
NOPBT | (7,742) | (10,702) | (6,734) | |||
NOPBT Margin | ||||||
Operating Taxes | 274 | 5,051 | ||||
Tax Rate | ||||||
NOPAT | (7,742) | (10,975) | (11,785) | |||
Net income | (8,102) -23.61% | (10,607) 18.30% | (8,967) 1,105.72% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 2,716 | 12,033 | ||||
BB yield | -57.99% | -53.10% | ||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | 3,893 | 3,712 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 23 | 22 | ||||
Net debt | 2,052 | (976) | (10,673) | |||
| Cash flow | ||||||
Cash from operating activities | (5,730) | (9,752) | (8,078) | |||
CAPEX | ||||||
Cash from investing activities | (2) | |||||
Cash from financing activities | 2,716 | 4,076 | 17,027 | |||
FCF | (6,433) | (11,428) | (13,982) | |||
| Balance | ||||||
Cash | 1,840 | 4,688 | 10,673 | |||
Long term investments | ||||||
Excess cash | 1,338 | 4,233 | 10,377 | |||
Stockholders' equity | (358) | 3,981 | 13,275 | |||
Invested Capital | 3,916 | 3,734 | 2,870 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 195,129 | 162,680 | 75,537 | |||
Price | 0.02 -73.33% | 0.09 -70.00% | 0.30 | |||
Market cap | 4,683 -68.01% | 14,641 -35.39% | 22,661 | |||
EV | 6,736 | 13,665 | 11,988 | |||
EBITDA | (7,742) | (10,702) | (6,731) | |||
EV/EBITDA | ||||||
Interest | 643 | 91 | 3,640 | |||
Interest/NOPBT | ||||||